XML 57 R47.htm IDEA: XBRL DOCUMENT v3.25.1
Variable Interest Entities (Tables)
3 Months Ended
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Balance Sheet Included Balances for VPFS and OSWP The Companies’ Consolidated Balance Sheets included balances for VPFS as follows:

 

 

March 31, 2025

 

 

December 31, 2024

 

(millions)

 

 

 

 

 

 

Prepayments(1)

 

$

 

 

$

 

Regulatory assets-current

 

 

119

 

 

 

124

 

Other current assets

 

 

108

 

 

 

41

 

Regulatory assets-noncurrent

 

 

998

 

 

 

1,040

 

    Total assets

 

$

1,225

 

 

$

1,205

 

Securities due within one year

 

$

163

 

 

$

163

 

Accrued interest, payroll
    and taxes

 

 

37

 

 

 

10

 

Securitization bonds

 

 

1,054

 

 

 

1,054

 

    Total liabilities

 

$

1,254

 

 

$

1,227

 

(1)
Prepayments are presented in other current assets in the Companies’ Consolidated Balance Sheets.
The Companies’ Consolidated Balance Sheets included balances for OSWP as follows:

 

 

March 31, 2025

 

 

December 31, 2024

 

(millions)

 

 

 

 

 

 

Cash and cash equivalents

 

$

159

 

 

$

70

 

Customer receivables

 

 

 

 

 

 

Prepayments(1)

 

 

7

 

 

 

10

 

Regulatory assets-current

 

 

4

 

 

 

6

 

Property, plant and equipment

 

 

6,632

 

 

 

5,844

 

Regulatory assets-noncurrent

 

 

52

 

 

 

52

 

Other deferred charges and
    other assets

 

 

 

 

 

 

       Total assets

 

$

6,854

 

 

$

5,982

 

Accrued interest, payroll
    and taxes

 

$

 

 

$

 

Other current liabilities

 

 

6

 

 

 

 

Asset retirement obligations-
    noncurrent
(2)

 

 

67

 

 

 

38

 

Other deferred credits and
    other liabilities

 

 

4

 

 

 

 

       Total liabilities

 

$

77

 

 

$

38

 

(1)
Prepayments are presented in other current assets in the Companies’ Consolidated Balance Sheets.
(2)
Asset retirement obligation-noncurrent are presented in other deferred credits and other liabilities in the Companies’ Consolidated Balance Sheets.